ALLIANCEBERNSTEIN HOLDING L.P. (AB)
AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
📈 **POSITIVE** • Low confidence analysis (36%) • Moderate positive clinical data • Good growth prospects **Sentiment:** Positive (55%) **Content type:** Clinical